At 4.1% CAGR, the South & Central America Digital Thoracic Drainage Devices Market is projected to be worth US$ 8.52 million by 2030, says Business Market Insights

According to Business Market Insights’ research, the South & Central America digital thoracic drainage devices market was valued at US$ 6.16 million in 2022 and is expected to reach US$ 8.52 million by 2030, registering a CAGR of 4.1% from 2022 to 2030. Need for digital thoracic drainage post-thoracic surgery and AI-powered thoracic diagnostics are among the critical factors attributed to the South & Central America digital thoracic drainage devices market expansion.        

The future of digital thoracic diagnostics is poised for a transformative shift, primarily fueled by the integration of Artificial Intelligence (AI) into the field. AI-enhanced diagnostics represent a pioneering trend that promises to revolutionize how thoracic conditions are detected and managed. Advanced machine learning algorithms, trained on a vast dataset of thoracic images, can quickly and accurately identify abnormalities, ranging from lung nodules to subtle lung tissue changes.

This development holds immense potential for earlier and more precise diagnoses, particularly in conditions like lung cancer, where early detection significantly impacts survival rates. AI can rapidly analyze large volumes of imaging data, allowing radiologists and clinicians to focus on more complex cases, interpret results with greater confidence, and expedite treatment decisions. Additionally, AI-driven predictive models can help access disease progression and treatment responses over time, aiding in personalized patient care. The integration of AI into thoracic diagnostics represents a paradigm shift, promising to enhance the efficiency and effectiveness of respiratory healthcare, ultimately leading to enhanced patient results and a more sustainable healthcare system.

On the contrary, lack of skilled personnel hampers the South & Central America digital thoracic drainage devices market. 

Based on product type, the South & Central America digital thoracic drainage devices market is segmented into single chamber and multiple chambers. The single chamber segment held 84.3% share of South & Central America digital thoracic drainage devices market in 2022, amassing US$ 5.19 million. It is projected to garner US$ 7.08 million by 2030 to expand at 4.0% CAGR during 2022–2030.

Based on application, the South & Central America digital thoracic drainage devices market is segmented into cardiac surgery, thoracic and pulmonary surgery, oncology and trauma, infectious diseases, and others. The thoracic and pulmonary surgery segment held 45.7% share of South & Central America digital thoracic drainage devices market in 2022, amassing US$ 2.81 million. It is projected to garner US$ 4.03 million by 2030 to expand at 4.6% CAGR during 2022–2030.

Based on end user, the South & Central America digital thoracic drainage devices market is segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment held 48.7% share of South & Central America digital thoracic drainage devices market in 2022, amassing US$ 3.00 million. It is projected to garner US$ 4.29 million by 2030 to expand at 4.6% CAGR during 2022–2030.

Based on country, the South & Central America digital thoracic drainage devices market has been categorized into Brazil, Argentina, and the Rest of South & Central America. Our regional analysis states that Brazil captured 47.8% share of South & Central America digital thoracic drainage devices market in 2022. It was assessed at US$ 2.94 million in 2022 and is likely to hit US$ 4.23 million by 2030, exhibiting a CAGR of 4.6% during 2022–2030.      

Key players operating in the South & Central America digital thoracic drainage devices market are Cardinal Health Inc, Getinge AB, Medela AG, Redax SpA, and Teleflex Inc, among others.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com